Vaccine related articles:
- Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
November 2019
Matanock A, Lee G, Gierke R, Kobayashi M, Leidner A, Pilishvili T. Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices MMWR. 2019;68(46);1069-75.
Based on a review of accrued evidence ACIP changed the recommendation for PCV13 use in adults…- Hsu CH, Kader M, Mahamud A, Bullard K, Jorba J, Agbor J, et al. Progress Toward Poliomyelitis Eradication — Pakistan, January 2018–September 2019 MMWR. 2019;68(45);1029-33.
This report updates previous reports on Pakistan’s polio eradication activities, progress, and challenges… - Jorba J, Diop OM, Iber J, Henderson E, Zhao K, Quddus A, et al. Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2018–June 2019 MMWR. 2019;68(45);1024-8.
This report presents data on cVDPV outbreaks detected during January 2018–June 2019 (as of September 30, 2019)…
October 2019
- Peck M, Gacic-Dobo M, Diallo MS, Nedelec Y, Sodha SS, Wallace AS. Global Routine Vaccination Coverage, 2018 MMWR. 2019;68(42);937-42.
Building on previous analyses and using the World Health Organization (WHO) and United Nations Children’s Fund (UNICEF) global vaccination coverage estimates as of 2018, this report presents global, regional, and national vaccination coverage estimates and trends, including vaccination dropout rates… - Hill HA, Singleton JA, Yankey D, Elam-Evans LD, Pingali SC, Kang Y. Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 — National Immunization Survey-Child, United States, 2016–2018 MMWR. 2019;68(41);913–8.
Coverage can be improved with increased access to providers and health insurance, administration of all recommended vaccines during office visits, and more effective patient education about vaccine safety and efficacy… - Seither R, Loretan C, Driver K, Mellerson JL, Knighton CL, Black CL. Vaccination Coverage with Selected Vaccines and Exemption Rates Among Children in Kindergarten — United States, 2018–19 School Year MMWR. 2019;68(41);905–12.
This report summarizes data collected by state and local immunization programs on vaccination coverage among children in kindergarten in 49 states, exemptions for kindergartners in 50 states, and provisional enrollment and grace period status for kindergartners in 30 states… - Epperson S, Davis CT, Brammer L, Elal AIA, Ajayi N, Barnes J, et al. Update: Influenza Activity — United States and Worldwide, May 19–September 28, 2019, and Composition of the 2020 Southern Hemisphere Influenza Vaccine MMWR. 2019;68(40);880-4.
Influenza viruses circulated widely in the Southern Hemisphere, with A(H3) viruses predominating in most regions, although influenza A(H1N1)pdm09 and influenza B/Victoria viruses predominated in several countries… - Lindley MC, Kahn KE, Bardenheier BH, D’Angelo DV, Dawood FS, Fink RV, et al. Vital Signs: Burden and Prevention of Influenza and Pertussis Among Pregnant Women and Infants — United States MMWR. 2019;68(40);885–92.
CDC and provider organizations’ resources are available to help providers convey strong, specific recommendations for influenza and Tdap vaccination that are responsive to pregnant women’s concerns… - Moffett DB, Llewellyn A, Singh H, Saxentoff E, Partridge J, Iakovenkoet M, al. Progress Toward Poliovirus Containment Implementation — Worldwide, 2018–2019 MMWR. 2019;68(38);825-9.
Twenty-six countries have designated 74 poliovirus type 2 poliovirus-essential facilities to retain poliovirus type 2 materials; these countries need to begin the certification process before the end of 2019… - Martinez M, Shukla H, Nikulin J, Mbaeyi C, Jorba J, Ehrhardt D. Progress Toward Poliomyelitis Eradication — Afghanistan, January 2018–May 2019 MMWR. 2019;68(33);729-33.
This report describes polio eradication activities and progress in Afghanistan during January 2018–May 2019 and updates previous reports… - Senkomago V, Henley SJ, Thomas CC, Mix JM, Markowitz LE, Saraiya M. Human Papillomavirus–Attributable Cancers — United States, 2012–2016 MMWR. 2019;68(33);724-8.
Ongoing surveillance for HPV-associated cancers can inform state-level and national-level HPV vaccination and cervical cancer screening efforts and monitor their long-term impact… - Walker TY, Elam-Evans LD, Yankey D, Markowitz LE, Williams CL, Fredua B, et al. National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2018 MMWR. 2019;68(33);718–23.
This report presents vaccination coverage estimates for 18,700 adolescents (8,928 [48%] females and 9,772 [52%] males) aged 13–17 years with adequate provider data… - Grohskopf LA, Alyanak E, Broder KR, Walter EB, Fry AM, Jernigan DB. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2019–20 Influenza Season MMWR. 2019;68(RR-3);1–21.
This report focuses on the recommendations for use of vaccines for the prevention and control of influenza during the 2019–20 season in the United States… - Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices MMWR. 2019;68(32);698–702.
This report describes progress in Nigeria polio eradication activities during January 2018–May 2019 and updates the previous report…
July 2019
- Adamu US, Archer WR, Braka F, Damisa E, Siddique A, Baig S, et al. Progress Toward Poliomyelitis Eradication — Nigeria, January 2018–May 2019 MMWR. 2019;68(29);642–6.
This report describes progress in Nigeria polio eradication activities during January 2018–May 2019 and updates the previous report… - Hills SL, Walter EB, Atmar RL, Fischer M. Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices MMWR. 2019;68(RR-2);1-33.
This report updates the 2010 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding prevention of Japanese encephalitis (JE) among U.S. travelers and laboratory workers (Fischer M, Lindsey N, Staples JE, Hills S. Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)… - Weil LM, Butler C, Howell KR, Sharr S, Paley GL, Huang AJW, et al. Notes from the Field: Conjunctivitis Caused by Toxigenic Corynebacterium ulcerans — Missouri, 2018 MMWR. 2019;68(27);615-6.
Because diphtheria toxoid–containing vaccines target diphtheria toxin, vaccination with these vaccines most likely prevents toxin-mediated disease caused by all toxigenic strains of Corynebacterium… - Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, et al. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016–2018 MMWR. 2019;68(26);587-91.
This report updates a previous report and describes the genetic characterization of measles and rubella viruses during 2016–2018… - Groenewold MR, Burrer SL, Ahmed F, Uzicanin A, Luckhaupt SE. Health-Related Workplace Absenteeism Among Full-Time Workers — United States, 2017–18 Influenza Season MMWR. 2019;68(26);577-82.
This report describes the results of workplace absenteeism surveillance analyses conducted during the high-severity 2017–18 influenza season (October 2017–September 2018)…
June 2019
- Xu X, Blanton L, Elal AIA, Alabi N, Barnes J, Biggerstaff M, et al. Update: Influenza Activity in the United States During the 2018–19 Season and Composition of the 2019–20 Influenza Vaccine MMWR. 2019;68(24);544-51.
The 2018–19 influenza season was a moderate severity season with two waves of influenza A activity of similar magnitude during the season: A(H1N1)pdm09 predominated from October 2018 to mid-February 2019, and A(H3N2) activity increased from mid-February through mid-May… - Hallowell BD, Parashar UD, Curns A, DeGroote NP, Tate JE. Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination — United States, 2000–2018 MMWR. 2019;68(24);539-43.
Implementation of the U.S. rotavirus vaccination program reduced the annual proportion of positive rotavirus tests, reduced peak rotavirus activity, and shortened the duration of the rotavirus season… - Hesse EM, Hibbs BF, Cano MV. Notes from the Field: Administration of Expired Injectable Influenza Vaccines Reported to the Vaccine Adverse Event Reporting System — United States, July 2018–March 2019 MMWR. 2019;68(23);529-30.
Vaccines should be inspected for expiration before they are administered or transported to other facilities… - Mere MO, Goodson JL, Chandio AK, Rana MS, Hasan Q, Teleb N, et al. Progress Toward Measles Elimination — Pakistan, 2000–2018 MMWR. 2019;68(22);505-10.
This report describes progress and challenges toward measles elimination in Pakistan during 2000–2018…
May 2019
- Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF, et al. Progress Toward Polio Eradication — Worldwide, January 2017–March 2019 MMWR. 2019;68(20);458-62.
This report describes global progress toward poliomyelitis eradication during January 1, 2017–March 31, 2019, and updates previous reports… - Carlson A, Riethman M, Gastañaduy P, Lee A, Leung J, Holshue M, et al. Notes from the Field: Community Outbreak of Measles — Clark County, Washington, 2018–2019 MMWR. 2019;68(19);446-7.
The current U.S. outbreaks underscore the importance of maintaining 2-dose measles vaccination coverage of ≥95% and of rapid public health responses in an era of increasing measles exposure threat, both in the United States and around the world… - McDonald R, Ruppert PS, Souto M, Johns DE, McKay K, Bessette N, et al. Notes from the Field: Measles Outbreaks from Imported Cases in Orthodox Jewish Communities — New York and New Jersey, 2018–2019 MMWR. 2019;68(19);444-5.
Health departments and clinicians should be aware of multiple ongoing measles outbreaks globally, and travelers should have evidence of measles immunity… - Foster MA, Hofmeister MG, Kupronis BA, Lin Y, Xia G, Yin S, et al. Increase in Hepatitis A Virus Infections — United States, 2013–2018 MMWR. 2019;68(18);413-5.
During 2016–2018, reports of hepatitis A infections in the United States increased by 294% compared with 2013–2015, related to outbreaks associated with contaminated food items, among men who have sex with men, and primarily, among persons who report drug use or homelessness… - CDC. Hepatitis Awareness Month and Testing Day — May 2019 MMWR. 2019;68(18);413.
May is designated as Hepatitis Awareness Month, and May 19 is Hepatitis Testing Day… - Patel M, Lee AD, Redd SB, Clemmons NS, McNall RJ, Cohn AC, et al. Increase in Measles Cases — United States, January 1–April 26, 2019 MMWR. 2019;68(17);402-4.
High coverage with measles, mumps, rubella (MMR) vaccination is the most effective way to limit transmission and maintain elimination of measles in the United States… - Zimmerman LA, Muscat M, Singh S, Mamou MB, Jankovic D, Datta S, et al. Progress Toward Measles Elimination — European Region, 2009–2018 MMWR. 2019;68(17);396-401.
This report updates a previous report and describes progress toward measles elimination in EUR during 2009–2018…
April 2019
- Wilson E, Hofmeister MG, McBee S, Briscoe J, Thomasson E, Olaisen RH, et al. Notes from the Field: Hepatitis A Outbreak Associated with Drug Use and Homelessness — West Virginia, 2018 MMWR. 2019;68(14);330-1.
Engaging partners to provide hepatitis A vaccine to persons at highest risk at all possible points of contact with the health care system and service providers might help improve vaccination coverage among groups at high risk… - Brennan J, Moore K, Sizemore L, Mathieson SA, Wester C, Dunn JR, et al. Notes from the Field: Acute Hepatitis A Virus Infection Among Previously Vaccinated Persons with HIV Infection — Tennessee, 2018 MMWR. 2019;68(14);328-9.
CDC guidelines recommend IG and a dose of vaccine as PEP for hepatitis A for previously unvaccinated persons who are immunocompromised, including persons with HIV infection…
March 2019
- Griffith J, Bozio CH, Poel AJ, Fitzpatrick K, DeBolt CA, Cassiday P, et al. Imported Toxin-Producing Cutaneous Diphtheria — Minnesota, Washington, and New Mexico, 2015–2018 MMWR. 2019;68(12);281-4.
This report summarizes the patient clinical information and response efforts conducted by the Minnesota, Washington, and New Mexico state health departments and CDC and emphasizes that health care providers should consider cutaneous diphtheria as a diagnosis in travelers with wound infections who have returned from countries with endemic diphtheria… - Kujawski SA, Midgley CM, Rha B, Lively JY, Nix WA, Curns AT, et al. Enterovirus D68–Associated Acute Respiratory Illness — New Vaccine Surveillance Network, United States, July–October, 2017 and 2018 MMWR. 2019;68(12);277-80.
This report details a preliminary characterization of EV-D68 testing and detections among emergency department (ED) and hospitalized patients with ARI at all NVSN sites during July 1–October 31, 2017, and the same period in 2018…
February 2019
- Han G, Batra N, Vallejo A, Schechter R, Zipprich J, Harriman K. Notes from the Field: Measles Outbreak in an Era of Stricter Immunization Requirements — California, March 2018 MMWR. 2019;68(8);201-2.
Prompt public health action and continued maintenance of a high level of population immunity to measles likely averted a larger outbreak… - Woodring J, Pastore R, Brink A, Ishikawa N, Takashima Y, Tohme RA. Progress Toward Hepatitis B Control and Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Western Pacific Region, 2005–2017 MMWR. 2019;68(8);195-200.
This report describes progress made to achieve hepatitis B control in the WPR and the steps taken to eliminate mother-to-child transmission (MTCT) of HBV during 2005–2017… - Doshani M, Weng M, Moore KL, Romero JR, Nelson NP. Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness MMWR. 2019;68(6);153-6.
This report provides recommendations for use of HepA vaccine among persons experiencing homelessness and updates previous ACIP recommendations for HepA vaccine that did not include homelessness as an indication for use of HepA vaccine for preexposure protection against HAV infection… - Doyle JD, Chung JR, Kim SS, Gaglani M, Raiyani C, Zimmerman RK, et al. Interim Estimates of 2018–19 Seasonal Influenza Vaccine Effectiveness — United States, February 2019 MMWR. 2019;68(6);135-9.
CDC continues to recommend influenza vaccination while influenza viruses are circulating in the community… - Blanton L, Dugan VG, Elal AIA, Alabi N, Barnes J, Brammer L, et al. Update: Influenza Activity — United States, September 30, 2018–February 2, 2019 MMWR. 2019;68(6);125-34.
Influenza vaccination remains the most effective way to prevent influenza illness… - Bauri M, Wilkinson AL, Ropa B, Feldon K, Snider CJ, Anand A, et al. Notes From The Field: Circulating Vaccine-Derived Poliovirus Type 1 and Outbreak Response — Papua New Guinea, 2018 MMWR. 2019;68(5);119-20.
Because of the outbreak, on July 12, 2018, CDC issued a Level 2 Travel Health Notice recommending that all travelers to Papua New Guinea be fully vaccinated against polio… - Kim DK, Hunter P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Adults Aged 19 Years or Older — United States, 2019 MMWR. 2019;68(5);115-8.
The 2019 adult immunization schedule summarizes ACIP recommendations in two tables and accompanying notes… - Robinson CL, Bernstein H, Romero JR, Szilagyi P. Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger — United States, 2019 MMWR. 2019;68(5);112-4.
The 2019 child and adolescent immunization schedule summarizes ACIP recommendations, including several changes from the 2018 immunization schedule, on the cover page, three tables, and notes found on the CDC immunization schedule website…
January 2019
- McKay SL, Kambui A, Taulung LA, Tippins A, Eckert M, Wharton AK, et al. Notes From The Field: Mumps Outbreak in a Recently Vaccinated Population — Kosrae, Federated States of Micronesia, August–December, 2017 MMWR. 2019;68(4);95-6.
This investigation underscored the importance of an accurate public health assessment of persons at risk for mumps to determine the most efficient and cost-effective outbreak response… - Hesse EM, Shimabukuro TT, Su JR, Hibbs BF, Dooling KL, Goud R, et al. Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018 MMWR. 2019;68(4);91-4.
Early RZV safety monitoring findings are consistent with prelicensure clinical trial data… - CDC. QuickStats: Percentage of Adults Aged 18–64 Years Who Had an Influenza Vaccination in the Past 12 Months, by Sex and Current Asthma Status — National Health Interview Survey, 2017 MMWR. 2019;68(2);48.
In 2017, adults aged 18–64 years with current asthma were more likely to have had an influenza vaccination in the past 12 months (47.9%) than those without asthma (36.4%)…
No comments:
Post a Comment